Practical, Evidence-Based Dimensions of Employing Oral Factor Xa Inhibitors in Patients with Acute PE: The Role of Key Clinical Factors—Severity of PE, Previous Anticoagulation, Bleeding Risk, Dosing, and Regimen Adherence—and Trial Data in Selecting an Evidence-Based Approach to Acute and Extended Management of PE - Professor Samuel Z. Goldhaber, MD

Practical, Evidence-Based Dimensions of Employing Oral Factor Xa Inhibitors in Patients with Acute PE: The Role of Key Clinical Factors—Severity of PE, Previous Anticoagulation, Bleeding Risk, Dosing, and Regimen Adherence—and Trial Data in Selecting an Evidence-Based Approach to Acute and Extended Management of PE - Professor Samuel Z. Goldhaber, MD

Published

July 17, 2015

Created by

CMEducation Resources symposium